Phathom Pharmaceuticals, Inc. short interest in 2022
In 2022, Phathom Pharmaceuticals, Inc.'s disclosed short interest ran from 11.19% of shares outstanding on 14 Jan 2022 to 4.55% on 30 Dec 2022, a change of -6.64 percentage points. The year's high was 14.69% on 31 Aug 2022 and its low 3.81% on 15 Dec 2022, averaging 8.43% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 34.19 days on 28 Feb 2022. Full history: Phathom Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 11.19% (14 Jan 2022)
- End of year
- 4.55% (30 Dec 2022)
- Change
- -6.64 pp
- High
- 14.69% (31 Aug 2022)
- Low
- 3.81% (15 Dec 2022)
- Average
- 8.43%
- Highest days to cover
- 34.19 (28 Feb 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 11.19% | 28.37 | |
| 31 Jan 2022 | 10.89% | 27.97 | |
| 15 Feb 2022 | 11.11% | 21.28 | |
| 28 Feb 2022 | 11.51% | 34.19 | |
| 15 Mar 2022 | 5.71% | 17.37 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 6.59% | 16.77 | |
| 14 Apr 2022 | 7.75% | 17.84 | |
| 29 Apr 2022 | 7.97% | 25.61 | |
| 13 May 2022 | 7.93% | 5.69 | 10-Q filed, results (8-K) |
| 31 May 2022 | 8.09% | 8.87 | |
| 15 Jun 2022 | 8.28% | 14.31 | |
| 30 Jun 2022 | 8.25% | 9.92 | |
| 15 Jul 2022 | 8.27% | 27.03 | |
| 29 Jul 2022 | 8.10% | 34.06 | |
| 15 Aug 2022 | 14.01% | 9.64 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 14.69% | 31.12 | |
| 15 Sep 2022 | 14.55% | 26.43 | |
| 30 Sep 2022 | 11.29% | 8.69 | |
| 14 Oct 2022 | 5.12% | 17.95 | |
| 31 Oct 2022 | 4.69% | 11.76 | |
| 15 Nov 2022 | 4.06% | 11.92 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 3.85% | 14.02 | |
| 15 Dec 2022 | 3.81% | 12.02 | |
| 30 Dec 2022 | 4.55% | 12.05 |
See also: Phathom Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.